Tag: SARS-CoV-2 RNA Controls

Twist Bioscience releases two synthetic SARS-CoV-2 RNA Controls

Twist Bioscience releases two synthetic SARS-CoV-2 RNA Controls

March 12, 2020 |

In California, Twist Bioscience Corporation announced the availability of two synthetic SARS-CoV-2 RNA Controls. Positive controls provide quality control measures for the development, verification, and validation for diagnostic tests including both next-generation sequencing (NGS) and reverse transcription-polymerase chain reaction (RT-PCR) assays; determination of the limit of detection; and monitoring of day-to-day test variations. Twist is […]

Read More